Metraipolis › archive › dc_b7352eff1eab

NRF1 predominantly causes EZH2 overexpression in cancer cells — Europe PMC PMID:42140904

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42140904
DOI
10.1038/s41419-[numero omesso]-4
License (as archived)
solo-consultazione
Archived
2026-11-02T05:38:07.645Z
SHA-256 of the archived text
851963492a39e49754417b422bd8bdf69de0bc0ccb132eca6eb68e4b4c5800bf
Stable URL of this page
https://metraipolis.com/documento/dc_b7352eff1eab

How to cite

NRF1 predominantly causes EZH2 overexpression in cancer cells — Europe PMC PMID:42140904 — Europe PMC (en), https://europepmc.org/article/MED/42140904 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b7352eff1eab (Metraipolis archive dc_b7352eff1eab, sha256 851963492a39e49754417b422bd8bdf69de0bc0ccb132eca6eb68e4b4c5800bf)
BibTeX
@misc{dcb7352eff1eab,
  title = {NRF1 predominantly causes EZH2 overexpression in cancer cells — Europe PMC PMID:42140904},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42140904},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b7352eff1eab; sha256 851963492a39e49754417b422bd8bdf69de0bc0ccb132eca6eb68e4b4c5800bf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42140904. Agents can read the archived copy with the MCP tool read_document.